GLAXOSMITHKLINE PHARMACEUTICALS
Back to All Ratios
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cash Profit Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Profit Margin (%) | 24.12 | 17.43 | 20.71 | 12.49 | 11.71 |
What is the latest Cash Profit Margin ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
| Year | Cash Profit Margin |
|---|---|
| Mar2025 | 24.12 |
| Mar2024 | 17.43 |
| Mar2023 | 20.71 |
| Mar2022 | 12.49 |
| Mar2021 | 11.71 |
How is Cash Profit Margin of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
| Years | Cash Profit Margin | % Change | |
|---|---|---|---|
| Mar2025 | 24.12 | 38.38 | |
| Mar2024 | 17.43 | -15.84 | |
| Mar2023 | 20.71 | 65.81 | |
| Mar2022 | 12.49 | 6.66 | |
| Mar2021 | 11.71 | - | |
Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,054.9 Cr | -3.9% | -10.3% | -9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹432,000.0 Cr | -0.4% | 5.3% | 13.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,076.0 Cr | -4.3% | -6.3% | 12.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,510.0 Cr | 0.4% | 8.2% | 44.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,921.0 Cr | 0.5% | 1.8% | 16.4% | Stock Analytics | |
| CIPLA | ₹106,150.0 Cr | -0.8% | -2.6% | -9.2% | Stock Analytics | |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAXOSMITHKLINE PHARMACEUTICALS | -3.9% |
-10.3% |
-9% |
| SENSEX | -5.5% |
-11.5% |
0.3% |
You may also like the below Video Courses